AstraZeneca is claiming victory in a court tussle with the European Union over allegations that the coronavirus vaccine-maker was not producing shots fast enough.
AstraZeneca said in a statement Friday that the EU's executive branch, the European Commission, had requested that the drug-maker deliver 120 million vaccine doses in total by the end of June 2021, but that a judge in Brussels ordered delivery of 80.2 million doses by 27 September 2021.
AstraZeneca was seen as a key pillar of the 27-member EU's vaccine rollout. Its contract with the Commission foresaw an initial 300 million doses being distributed, with an option for another 100 million.
The judgement also acknowledged that the difficulties experienced by AstraZeneca in this unprecedented situation had a substantial impact on the delay, the company said.
AstraZeneca now looks forward to renewed collaboration with the European Commission to help combat the pandemic in Europe.
Dear Reader,
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.
Digital Editor
RECOMMENDED FOR YOU